Whitehawk Therapeutics, Inc. Common Stock (WHWK) Stock Price

WHWKStock

$5.08+180.46%52W

Market Cap$289.61M

P/E—

PEG Ratio—

Div yield—

Beta0.93

WHWK Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)51.42%

Price vs S&P 500 (4W)29.56%

VGM Score45.15

Book Value / Share (Quarterly)$2.46

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-22.28%

Cash Flow / Share (Quarterly)$-2.28

Price vs S&P 500 (YTD)89.69%

Gross Margin (TTM)88.72%

Net Profit Margin (TTM)99.42%

EPS (TTM)$-3.59

10-Day Avg Trading Volume0.33M

EPS Excl Extra (TTM)$-3.59

Revenue Growth (5Y)-13.79%

EPS (Annual)$-0.44

ROI (Annual)-15.11%

Gross Margin (Annual)89.36%

Net Profit Margin (5Y Avg)-2206.09%

Cash / Share (Quarterly)$2.61

ROA (Last FY)-13.66%

Revenue Growth TTM (YoY)-72.50%

EBITD / Share (TTM)$-2.26

ROE (5Y Avg)-63.58%

Operating Margin (TTM)87.41%

Cash Flow / Share (Annual)$-2.08

P/B Ratio2.18x

P/B Ratio (Quarterly)1.40x

Net Income / Employee (Annual)$-895,500

Net Interest Coverage (TTM)-193.55x

ROA (TTM)-74.01%

EPS Incl Extra (Annual)$-0.44

Current Ratio (Annual)10.26x

Quick Ratio (Quarterly)11.13x

3-Month Avg Trading Volume0.45M

52-Week Price Return180.46%

Revenue / Employee (TTM)$0

P/S Ratio (Annual)35.45x

Asset Turnover (Annual)0.05x

52-Week High$5.50

Operating Margin (5Y Avg)-2251.81%

EPS Excl Extra (Annual)$-0.44

CapEx CAGR (5Y)94.17%

26-Week Price Return62.67%

Quick Ratio (Annual)10.03x

13-Week Price Return13.49%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)11.36x

Enterprise Value$218.53M

Revenue / Share Growth (5Y)-50.84%

Asset Turnover (TTM)0.23x

Revenue / Employee (Annual)$310,700

Inventory Turnover (Annual)0.29x

Pretax Margin (Annual)-288.26%

Cash / Share (Annual)$3.09

3-Month Return Std Dev60.50%

Net Income / Employee (TTM)$-5,035,000

ROE (Last FY)-15.11%

Net Interest Coverage (Annual)-330.67x

EPS Basic Excl Extra (Annual)$-0.44

Receivables Turnover (TTM)2.42x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-3.59

Receivables Turnover (Annual)2.42x

ROI (TTM)-79.63%

P/S Ratio (TTM)9.12x

Pretax Margin (5Y Avg)-2206.09%

Revenue / Share (Annual)$0.15

Price vs S&P 500 (52W)162.15%

Year-to-Date Return101.65%

5-Day Price Return2.52%

EPS Normalized (Annual)$-0.44

ROA (5Y Avg)-51.29%

Net Profit Margin (Annual)-288.26%

Month-to-Date Return26.75%

EBITD / Share (Annual)$-0.57

Operating Margin (Annual)-379.76%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-62.90%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-3.59

P/B Ratio (Annual)0.84x

Inventory Turnover (TTM)0.29x

Pretax Margin (TTM)99.42%

Book Value / Share (Annual)$2.89

Price vs S&P 500 (13W)10.69%

Beta0.93x

Revenue / Share (TTM)$0.00

ROE (TTM)-79.63%

52-Week Low$1.68

gGradeF

mGradeB

vgmGradeC

WHWK Earnings Surprise History

Q2 25-0.76est. -0.17

Q3 25-0.25est. -0.22

Q4 25-0.34est. -0.27

Q1 26-0.32est. -0.33

Q2 26-0.20est. -0.26

WHWK Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

3.92

4.00

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
WHWKWhitehawk Therapeutics, Inc. Common Stock	—	F	B	$5.08
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About Whitehawk Therapeutics, Inc. Common Stock

Whitehawk Therapeutics is a preclinical-stage oncology company developing next-generation antibody-drug conjugates for difficult-to-treat cancers. Its three-asset ADC portfolio is engineered to overcome first-generation limitations and improve therapeutic efficacy.